Cassava Sciences IncNASDAQ:SAVA
- LAST PRICE29.4650
- TODAY'S CHANGE (%)1.1250 (3.9697%)
- Bid / Lots29.4300/ 2
- Ask / Lots29.5000/ 10
- Open / Previous Close28.7100 / 28.3400
- Day Range
- 52 Week Range
- Volume612,253
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SAVA |
|---|---|---|
| 09:32 ET | 4526 | 28.5657 |
| 09:34 ET | 7300 | 28.615 |
| 09:36 ET | 553 | 28.615 |
| 09:38 ET | 35989 | 28.565 |
| 09:39 ET | 1585 | 28.5983 |
| 09:41 ET | 1307 | 28.3601 |
| 09:43 ET | 400 | 28.47 |
| 09:45 ET | 230 | 28.47 |
| 09:48 ET | 2600 | 28.53 |
| 09:50 ET | 1350 | 28.4302 |
| 09:54 ET | 1629 | 28.53 |
| 09:56 ET | 3459 | 28.35 |
| 09:57 ET | 1200 | 28.34 |
| 09:59 ET | 900 | 28.35 |
| 10:01 ET | 100 | 28.35 |
| 10:03 ET | 2923 | 28.49 |
| 10:06 ET | 5593 | 28.53 |
| 10:08 ET | 26094 | 28.95 |
| 10:10 ET | 10839 | 28.9 |
| 10:12 ET | 20802 | 28.99 |
| 10:14 ET | 22191 | 29.075 |
| 10:15 ET | 20820 | 29.0424 |
| 10:17 ET | 25931 | 29.1984 |
| 10:19 ET | 9703 | 29.0893 |
| 10:21 ET | 13718 | 29.1518 |
| 10:24 ET | 16407 | 29.3499 |
| 10:26 ET | 3572 | 29.26 |
| 10:28 ET | 3169 | 29.21 |
| 10:30 ET | 3568 | 29.24 |
| 10:32 ET | 4870 | 29.0075 |
| 10:33 ET | 4650 | 29.1869 |
| 10:35 ET | 3792 | 29.2 |
| 10:37 ET | 1300 | 29.05 |
| 10:39 ET | 3200 | 29.24 |
| 10:42 ET | 600 | 29.19 |
| 10:44 ET | 14662 | 29.19 |
| 10:46 ET | 621 | 29.175 |
| 10:48 ET | 3822 | 29.11 |
| 10:50 ET | 4654 | 28.9999 |
| 10:51 ET | 4349 | 28.86 |
| 10:53 ET | 1650 | 29.0999 |
| 10:55 ET | 2846 | 28.93 |
| 10:57 ET | 1023 | 28.9301 |
| 11:00 ET | 1608 | 28.96 |
| 11:02 ET | 4930 | 28.955 |
| 11:06 ET | 1500 | 29.06 |
| 11:08 ET | 3085 | 29.15 |
| 11:09 ET | 47738 | 29.3423 |
| 11:11 ET | 14013 | 29.4502 |
| 11:13 ET | 1877 | 29.2999 |
| 11:15 ET | 1490 | 29.34 |
| 11:18 ET | 1077 | 29.3 |
| 11:20 ET | 5792 | 29.19 |
| 11:22 ET | 3547 | 29.19 |
| 11:24 ET | 1999 | 29.175 |
| 11:26 ET | 1400 | 29.2 |
| 11:27 ET | 200 | 29.2 |
| 11:29 ET | 1388 | 29.235 |
| 11:31 ET | 1875 | 29.3 |
| 11:33 ET | 1800 | 29.3053 |
| 11:36 ET | 600 | 29.3448 |
| 11:38 ET | 8558 | 29.22 |
| 11:40 ET | 1900 | 29.26 |
| 11:42 ET | 400 | 29.31 |
| 11:44 ET | 1153 | 29.26 |
| 11:45 ET | 1091 | 29.3772 |
| 11:47 ET | 1996 | 29.3 |
| 11:49 ET | 1364 | 29.27 |
| 11:54 ET | 100 | 29.304 |
| 11:56 ET | 7699 | 29.21 |
| 11:58 ET | 541 | 29.255 |
| 12:00 ET | 3869 | 29.23 |
| 12:02 ET | 3375 | 29.2 |
| 12:03 ET | 300 | 29.19 |
| 12:05 ET | 100 | 29.1601 |
| 12:07 ET | 2887 | 29.15 |
| 12:09 ET | 2117 | 29.1011 |
| 12:12 ET | 270 | 29.2099 |
| 12:16 ET | 1390 | 29.13 |
| 12:18 ET | 1272 | 29.1 |
| 12:20 ET | 1300 | 29.01 |
| 12:21 ET | 969 | 29.1399 |
| 12:23 ET | 14685 | 29.04 |
| 12:25 ET | 4029 | 28.88 |
| 12:27 ET | 12222 | 29.12 |
| 12:30 ET | 2165 | 29.16 |
| 12:32 ET | 1232 | 29.1758 |
| 12:34 ET | 300 | 29.1 |
| 12:38 ET | 1013 | 29.2043 |
| 12:39 ET | 200 | 29.155 |
| 12:41 ET | 671 | 29.18 |
| 12:43 ET | 1123 | 29.186 |
| 12:45 ET | 800 | 29.1016 |
| 12:48 ET | 600 | 29.08 |
| 12:50 ET | 1607 | 28.98 |
| 12:52 ET | 1000 | 28.89 |
| 12:54 ET | 1400 | 28.9596 |
| 12:56 ET | 700 | 28.97 |
| 12:57 ET | 1018 | 28.97 |
| 01:01 ET | 1018 | 28.9891 |
| 01:03 ET | 4931 | 29.02 |
| 01:06 ET | 200 | 29.03 |
| 01:08 ET | 600 | 29.035 |
| 01:10 ET | 500 | 29.0625 |
| 01:14 ET | 2067 | 28.95 |
| 01:15 ET | 786 | 29.01 |
| 01:17 ET | 300 | 29.06 |
| 01:19 ET | 3827 | 29.08 |
| 01:21 ET | 100 | 29.18 |
| 01:24 ET | 200 | 29.22 |
| 01:26 ET | 1200 | 29.255 |
| 01:28 ET | 4525 | 29.29 |
| 01:30 ET | 9368 | 29.27 |
| 01:32 ET | 13815 | 29.53 |
| 01:33 ET | 3215 | 29.48 |
| 01:35 ET | 4720 | 29.47 |
Sep 9, 2024
DJ Cassava Sciences' Executive Chairman Rick Barry Becomes CEO, from 9:06AM ET on Monday Sep 09, 2024 by Dow Jones
9:06AM ET on Monday Sep 09, 2024 by Dow JonesCassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones
8:30AM ET on Monday Sep 09, 2024 by Dow JonesPress Release: Cassava Sciences Names Rick Barry as Chief Executive Officer, from 8:30AM ET on Monday Sep 09, 2024 by Dow Jones
8:30AM ET on Monday Sep 09, 2024 by Dow Jones
Sep 3, 2024
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference, from 8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones
8:31AM ET on Tuesday Sep 03, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Cassava Sciences Inc | 1.4B | -72.7x | --- |
Disc Medicine Inc | 1.4B | -13.1x | --- |
ARS Pharmaceuticals Inc | 1.3B | -27.5x | --- |
Spyre Therapeutics Inc | 1.5B | -1.9x | --- |
Pharvaris NV | 1.1B | -7.7x | --- |
Belite Bio Inc | 1.5B | -39.6x | --- |
Company Information
Cassava Sciences, Inc. is a clinical-stage biopharmaceutical company focused on neuroscience. The Company's science is based on stabilizing, but not removing, a critical protein in the Alzheimer’s brain. Its scientific approach for the treatment of Alzheimer's disease seeks to simultaneously suppress both neurodegeneration and neuroinflammation. It has two biopharmaceutical assets under development: Simufilam and SavaDx. Simufilam, its lead therapeutic product candidate, is an oral treatment for Alzheimer’s disease dementia. Simufilam targets an altered form of a protein called filamin A (FLNA) in the Alzheimer’s brain. It is conducting two randomized placebo-controlled Phase III clinical trials of oral simufilam in patients with Alzheimer’s disease dementia. SavaDx, its lead investigational diagnostic product candidate, is a way to detect the presence of Alzheimer’s disease from a small sample of blood. SavaDx is a research-use only, non-safety related exploratory biomarker.
Contact Information
- Headquarters
- 6801 N CAPITAL OF TEXAS HIGHWAY BUILDING 1; SUITE 300AUSTIN, TX, United States 78731
- Phone
- 512-501-2444
- Fax
- 512-614-0414
Executives
- Non-Executive Independent Chairman of the Board
- Claude Nicaise
- Executive Chairman of the Board
- Richard Barry
- Chief Financial Officer
- Eric Schoen
- Senior Vice President, General Counsel
- R. Christopher Cook
- Chief Medical Officer
- James Kupiec
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.4B |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 48.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | -0.60 |
EPS | $-0.41 |
Book Value | $3.25 |
P/E Ratio | -72.7x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
